Dörner T, Furie RJ. Novel paradigms in systemic lupus erythematosus. The Lancet. 2019;393(10188):2344–58.

Article  Google Scholar 

Fava A, Petri MJ. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1–13.

Article  PubMed  Google Scholar 

Suárez-Fueyo A, Bradley SJ, Tsokos GCJ. T cells in systemic lupus erythematosus. Curr Opin Immunol. 2016;43:32–8.

Article  PubMed  PubMed Central  Google Scholar 

Hoffman RWJ. T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol. 2004;113(1):4–13.

Article  CAS  PubMed  Google Scholar 

Pernis AJ. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med. 2009;265(6):644–52.

Article  CAS  PubMed  Google Scholar 

Martin JC, Baeten DL, Josien RJ. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. Clin Immunol. 2014;154(1):1–12.

Article  CAS  PubMed  Google Scholar 

Crispín JC, Tsokos GCJ. IL-17 in systemic lupus erythematosus. J Biomed Biotechnol. 2010. https://doi.org/10.1155/2010/943254.

Article  PubMed  PubMed Central  Google Scholar 

Koga T, Ichinose K, Kawakami A, Tsokos GCJ. The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target. Expert Rev Clin Immunol. 2019;15(6):629–37.

Article  CAS  PubMed  Google Scholar 

Zanin-Zhorov A, Weiss JM, Nyuydzefe MS, Chen W, Scher JU, Mo R, et al. Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proc Natl Acad Sci. 2014;111(47):16814–9.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Jie X-L, Luo Z-R, Yu J, Tong Z-R, Li Q-Q, Wu J-H, et al. Pi-Pa-Run-Fei-Tang alleviates lung injury by modulating IL-6/JAK2/STAT3/IL-17 and PI3K/AKT/NF-κB signaling pathway and balancing Th17 and Treg in murine model of OVA-induced asthma. J Ethnopharmacol. 2023;317:116719.

Article  CAS  PubMed  Google Scholar 

Gu Y-J, Sun W-Y, Zhang S, Li X-R, Wei W. Targeted blockade of JAK/STAT3 signaling inhibits proliferation, migration and collagen production as well as inducing the apoptosis of hepatic stellate cells. Int J Mol Med. 2016;38(3):903–11.

Article  CAS  PubMed  Google Scholar 

Yoshida N, He F, Kyttaris VCJ. T cell–specific STAT3 deficiency abrogates lupus nephritis. Lupus. 2019;28(12):1468–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alvarado-Sánchez B, Hernández-Castro B, Portales-Pérez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2006;27(2):110–8.

Article  PubMed  Google Scholar 

Wu H, Yan S, Chen J, Luo X, Li P, Jia X, et al. JAK1-STAT3 blockade by JAK inhibitor SHR0302 attenuates inflammatory responses of adjuvant-induced arthritis rats and decreases Th17 and total B cells. Joint Bone Spine. 2016;83(5):525–32.

Article  CAS  PubMed  Google Scholar 

Ihle JNJ. Cytokine receptor signalling. Nature. 1995;377(6550):591–4.

Article  ADS  CAS  PubMed  Google Scholar 

Fasching P, Stradner M, Graninger W, Dejaco C, Fessler JJ. Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules. 2017;22(1):134.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Liu T, Duan Y, Chang Y, Chang L, Liu C, et al. Single-cell analysis highlights a population of Th17-polarized CD4+ naïve T cells showing IL6/JAK3/STAT3 activation in pediatric severe aplastic anemia. J Autoimmun. 2023;136:103026.

Article  CAS  PubMed  Google Scholar 

Yarilina A, Xu K, Chan C, Ivashkiv LBJ. Regulation of inflammatory responses in tumor necrosis factor–activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthr Rheum. 2012;64(12):3856–66.

Article  CAS  Google Scholar 

Maeshima K, Yamaoka K, Kubo S, Nakano K, Iwata S, Saito K, et al. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells. Arthr Rheum. 2012;64(6):1790–8.

Article  CAS  Google Scholar 

Furumoto Y, Smith CK, Blanco L, Zhao W, Brooks SR, Thacker SG, et al. Tofacitinib ameliorates murine lupus and its associated vascular dysfunction. Arthr Rheumatol. 2017;69(1):148–60.

Article  CAS  Google Scholar 

Kubo S, Nakayamada S, Tanaka YJ. Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update. Expert Rev Clin Immunol. 2019;15(7):693–700.

Article  CAS  PubMed  Google Scholar 

Jhun JY, Moon S-J, Yoon BY, Byun JK, Kim EK, Yang EJ, et al. Grape seed proanthocyanidin extract–mediated regulation of STAT3 proteins contributes to treg differentiation and attenuates inflammation in a murine model of obesity-associated arthritis. PLoS ONE. 2013;8(11):e78843.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Mudter J, Yu J, Zufferey C, Brüstle A, Wirtz S, Weigmann B, et al. IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo. Inflamm Bowel Dis. 2011;17(6):1343–58.

Article  PubMed  Google Scholar 

Huber M, Brüstle A, Reinhard K, Guralnik A, Walter G, Mahiny A, et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci. 2008;105(52):20846–51.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Voon DCC, Hor YT, Ito YJ. The RUNX complex: reaching beyond haematopoiesis into immunity. Immunology. 2015;146(4):523–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, Pappu B, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol. 2008;181(12):8391–401.

Article  CAS  PubMed  Google Scholar 

Zheng J, Chan P-L, Liu Y, Qin G, Xiang Z, Lam K-T, et al. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner. PLoS ONE. 2013;8(12):e82203.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Cai J, Wang D, Zhang G, Guo XJ. The role of PD-1/PD-L1 axis in treg development and function: implications for cancer immunotherapy. OncoTargets therapy. 2019;12:8437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DAJ. TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells. J Immunol. 2006;176(6):3321–9.

Article  CAS  PubMed  Google Scholar 

Hosseini A, Gharibi T, Marofi F, Babaloo Z, Baradaran BJ. CTLA-4: from mechanism to autoimmune therapy. Int Immunopharmacol. 2020;80:106221.

Article  CAS  PubMed  Google Scholar 

Hussein H, Denanglaire S, Van Gool F, Azouz A, Ajouaou Y, El-Khatib H, et al. Multiple environmental signaling pathways control the differentiation of RORγt-expressing regulatory T cells. Front Immunol. 2020;10:3007.

Article  PubMed  PubMed Central  Google Scholar 

Hanaei S, Sanati G, Zoghi S, Gharibzadeh S, Ziaee V, Rezaei NJ. The status of FOXP3 gene methylation in pediatric systemic lupus erythematosus. Allergol Immunopathol. 2020;48(4):332–8.

Article  CAS  Google Scholar 

Wang WJ, Zhang H, Chen ZQ, Zhang W, Liu XM, Fang JY, Liu FJ, Kwak-Kim J. Endometrial TGF-β, IL-10, IL-17 and autophagy are dysregulated in women with recurrent implantation failure with chronic endometritis. Reprod Biol Endocrinol. 2019;17(1):1–9.

Article  Google Scholar 

Xu J, Wang J, Min Q, Wang W, Qin Y, Lei L, et al. Characterisation of IL-21 and IL-21Rα in grass carp: IL-21-producing cells are upregulated during flavobacterium columnare infection. Aquac Fish. 2021. https://doi.org/10.1016/j.aaf.2021.06.002.

Article  Google Scholar 

Magatti M, Masserdotti A, Bonassi Signoroni P, Vertua E, Stefani FR, Silini AR, et al. B lymphocytes as targets of the immunomodulatory properties of human amniotic mesenchymal stromal cells. Front Immunol. 2020;11:1156.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang R, Mele F, Worley L, Langlais D, Rosain J, Benhsaien I, et al. Human T-bet governs innate and innate-like adaptive IFN-γ immunity against mycobacteria. Cell. 2020;183(7):1826–47.

Article  CAS  PubMed  PubMed Central